Content area

Abstract

Antigen specificity is the central trait distinguishing adaptive from innate immune function. Assembly of antigen-specific T cell and B cell receptors occurs through V(D)J recombination mediated by the Recombinase Activating Gene endonucleases RAG1 and RAG2 (collectively called RAG). In the absence of RAG, mature T and B cells do not develop and thus RAG is critically associated with adaptive immune function. In addition to adaptive T helper 2 (Th2) cells, group 2 innate lymphoid cells (ILC2s) contribute to type 2 immune responses by producing cytokines like Interleukin-5 (IL-5) and IL-13. Although it has been reported that RAG expression modulates the function of innate natural killer (NK) cells, whether other innate immune cells such as ILC2s are affected by RAG remains unclear. We find that in RAG-deficient mice, ILC2 populations expand and produce increased IL-5 and IL-13 at steady state and contribute to increased inflammation in atopic dermatitis (AD)-like disease. Furthermore, we show that RAG modulates ILC2 function in a cell-intrinsic manner independent of the absence or presence of adaptive T and B lymphocytes. Lastly, employing multiomic single cell analyses of RAG1 lineage-traced cells, we identify key transcriptional and epigenomic ILC2 functional programs that are suppressed by a history of RAG expression. Collectively, our data reveal a novel role for RAG in modulating innate type 2 immunity through suppression of ILC2s.

Details

1009240
Title
RAG suppresses group 2 innate lymphoid cells
Author
Ver Heul Aaron M 1   VIAFID ORCID Logo  ; Mack, Madison 2 ; Zamidar Lydia 3 ; Tamari Masato 3 ; Ting-Lin, Yang 4   VIAFID ORCID Logo  ; Trier, Anna M 4 ; Do-Hyun, Kim 5 ; Janzen-Meza, Hannah 1 ; Van Dyken Steven J 6 ; Chyi-Song, Hsieh 7 ; Karo, Jenny M 8 ; Sun, Joseph C 8 ; Kim, Brian S 9   VIAFID ORCID Logo 

 https://ror.org/036c27j91 Division of Allergy and Immunology, Department of Medicine, Washington University School of Medicine St. Louis United States 
 Immunology and Inflammation Research Therapeutic Area, Sanofi Cambridge United States 
 https://ror.org/04a9tmd77 Kimberly and Eric J. Waldman Department of Dermatology, Icahn School of Medicine at Mount Sinai New York United States, https://ror.org/04a9tmd77 Mark Lebwohl Center for Neuroinflammation and Sensation, Icahn School of Medicine at Mount Sinai New York United States, https://ror.org/04a9tmd77 Marc and Jennifer Lipschultz Precision Immunology Institute, Icahn School of Medicine at Mount Sinai New York United States, https://ror.org/04a9tmd77 Friedman Brain Institute, Icahn School of Medicine at Mount Sinai New York United States 
 https://ror.org/036c27j91 Division of Dermatology, Department of Medicine, Washington University School of Medicine St. Louis United States 
 https://ror.org/036c27j91 Department of Pathology and Immunology, Washington University School of Medicine St. Louis United States, https://ror.org/046865y68 Department of Life Science, College of Natural Sciences, Hanyang University Seoul Republic of Korea 
 https://ror.org/036c27j91 Department of Pathology and Immunology, Washington University School of Medicine St. Louis United States 
 https://ror.org/036c27j91 Division of Rheumatology, Department of Medicine, Washington University School of Medicine St. Louis United States 
 https://ror.org/02r109517 Immunology and Microbial Pathogenesis Program, Graduate School of Medical Sciences, Weill Cornell Medical College New York United States, https://ror.org/02yrq0923 Immunology Program, Memorial Sloan Kettering Cancer Center New York United States 
 https://ror.org/04a9tmd77 Kimberly and Eric J. Waldman Department of Dermatology, Icahn School of Medicine at Mount Sinai New York United States, https://ror.org/04a9tmd77 Mark Lebwohl Center for Neuroinflammation and Sensation, Icahn School of Medicine at Mount Sinai New York United States, https://ror.org/04a9tmd77 Marc and Jennifer Lipschultz Precision Immunology Institute, Icahn School of Medicine at Mount Sinai New York United States, https://ror.org/04a9tmd77 Friedman Brain Institute, Icahn School of Medicine at Mount Sinai New York United States, https://ror.org/04a9tmd77 Allen Discovery Center for Neuroimmune Interactions, Icahn School of Medicine at Mount Sinai New York United States 
Publication title
eLife; Cambridge
Volume
13
Publication year
2025
Publication date
2025
Publisher
eLife Sciences Publications Ltd.
Place of publication
Cambridge
Country of publication
United Kingdom
University/institution
U.S. National Institutes of Health/National Library of Medicine
Publication subject
e-ISSN
2050084X
Source type
Scholarly Journal
Language of publication
English
Document type
Journal Article
Publication history
 
 
Online publication date
2025-05-06
Publication history
 
 
   First posting date
06 May 2025
ProQuest document ID
3204558862
Document URL
https://www.proquest.com/scholarly-journals/rag-suppresses-group-2-innate-lymphoid-cells/docview/3204558862/se-2?accountid=208611
Copyright
© 2024, Ver Heul et al This article is distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use and redistribution provided that the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
Last updated
2025-05-16
Database
ProQuest One Academic